Validation of the Sarcoidosis Health Questionnaire in a non-US population

Respirology

Volumn 17, Issue 3, 2012, Pages 519-524

  De Boer, Sally ^a   Wilsher, Margaret L ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

health status; quality of life; questionnaire; respiratory function test; sarcoidosis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SARCOIDOSIS; SHORT FORM 36; TEACHING HOSPITAL; VALIDATION PROCESS;

ADULT; EUROPE; FATIGUE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84859038433     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02134.x     Document Type: Article

References (18)

1. Hunninghake GW, Costabel U, Ando M, et al,. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc. Diffuse Lung Dis. 1999; 16: 149-73.
2. Cox CE, Donohue JF, Brown CD, et al,. Health-related quality of life of persons with sarcoidosis. Chest 2004; 125: 997-1004.
3. Muller NL, Mawson JB, Mathieson JR, et al,. Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 1989; 171: 613-18.
4. Cox CE, Donohue JF, Brown CD, et al,. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am. J. Respir. Crit. Care Med. 2003; 168: 323-9.
5. Judson MA, Baughman RP, Teirstein AS, et al,. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 1999; 16: 75-86.
6. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am. J. Respir. Crit. Care Med. 1995; 152: 1107-36.
7. Hankinson JL, Odencrantz JR, Fedan KB,. Spirometric reference values from a sample of the general U.S. population. Am. J. Respir. Crit. Care Med. 1999; 159: 179-87.
8. Brazier JE, Harper R, Jones NM, et al,. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 160-4.
9. Mahler DA, Mackowiak JI,. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995; 107: 1585-9.
10. Chang JA, Curtis JR, Patrick DL, et al,. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999; 116: 1175-82.
11. Ware JE, Snow KK, Kosinski M, et al,. SF-36 Health Survey. Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, MA, 1993.
12. De Vries J, Michielsen H, Van Heck GL, et al,. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br. J. Health Psychol. 2004; 9: 279-91.
13. Gvozdenovic BS, Mihailovic-Vucinic V, Ilic-Dudvarski A, et al,. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir. Med. 2008; 102: 1636-42.
14. Michielsen HJ, Peros-Golubicic T, Drent M, et al,. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration 2007; 74: 401-5.
15. Wirnsberger RM, Drent M, Hekelaar N, et al,. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur. Respir. J. 1997; 10: 1450-5.
16. Michielsen HJ, Drent M, Peros-Golubicic T, et al,. Fatigue is associated with quality of life in sarcoidosis patients. Chest 2006; 130: 989-94.
17. Drent M, Wirnsberger RM, de Vries J, et al,. Association of fatigue with an acute phase response in sarcoidosis. Eur. Respir. J. 1999; 13: 718-22.
18. Juniper EF, Guyatt GH, Willan A, et al,. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J. Clin. Epidemiol. 1994; 47: 81-7.